LMAT

NASD LeMaitre Vascular, Inc.
Sep 29, 2026 · 2:55 PM ET DELAYED Market Open

$81.93 ↓ -0.41 (-0.50%) Trading Down from the previous close of $82.34, $0.48 below the day’s high of $82.41

YTD change
+1.02%
vs 20-day SMA
+1.91%
vs 200-day SMA
-13.44%

Price ranges

Previous day
$80.39 $82.82
open $81.29 close $82.34
+$1.05 (+1.29%)
Today
$81.25 $82.41
open $82.13 now $81.93
-$0.20 (-0.24%)
Past week
$79.20 $82.82
from $79.20 now $81.93
+$2.73 (+3.45%)
Past month
$78.22 $83.07
from $80.45 now $81.93
+$1.48 (+1.84%)
This year
$78.22 $118.01
from $81.10 now $81.93
+$0.83 (+1.02%)

Price & Performance

-24.53 (-22.95%) / 6M

$75.71$90.63$105.56$120.48Mar 30Jun 29Sep 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 30.6% away from all-time highs of $118.01
  • LMAT is up 1% since the beginning of the year
  • LMAT is down 4% over the past 12 months
  • LMAT is up 2% over the past 1 month
  • 8% of all LMAT investors are betting against LMAT

LMAT reads neutral: price sits above one of the two key moving averages, the 12-month move is -3.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.74
Earnings momentum -7.8% Quarterly EPS growth
Quarterly change -7.8%

Valuation

P/E ratio 28.60
Enterprise value $1.8B
Beta 0.72

Balance sheet & scale

Income$65.7K
Revenue$262.4M
Cash$376.2M
Debt$190.3K
Income / Debt 0.35×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap $1.9B

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Competitor comparison

TickerCompany PriceChange
JNJ.CAT JOHNSON & JOHNSON CDR CAD HEDGED $34.72 +0.35%
BDX Becton, Dickinson and Company $183.83 +0.01%
DXCM DexCom, Inc. $86.68 +0.07%
MDLN Medline, Inc. Class A $35.07 +1.07%
WST West Pharmaceutical Services, Inc. $375.65 +1.41%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.